Upgrade to SI Premium - Free Trial

Bright Minds Biosciences (DRUG)

63.38 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/25 *Est.)

Latest Headlines

Bright Minds Biosciences to Present at Upcoming Conferences September 4, 2026 4:30 PM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Bright Minds Biosciences Inc. (DRUG) August 20, 2026 6:59 AM - StreetInsider Form 6-K BRIGHT MINDS BIOSCIENCES For: Jun 30 August 17, 2026 6:04 AM - SEC Filing Form SCHEDULE 13G/A BRIGHT MINDS BIOSCIENCES Filed by: Cormorant Asset Management, LP August 14, 2026 2:02 PM - SEC Filing Form S-8 BRIGHT MINDS BIOSCIENCES August 13, 2026 6:05 AM - SEC Filing Form SCHEDULE 13G/A BRIGHT MINDS BIOSCIENCES Filed by: Adage Capital Management, L.P. August 12, 2026 12:05 PM - SEC Filing Vistagen names neuroscience veteran Douglas Williamson to its board July 31, 2026 8:30 AM - StreetInsider Vistagen Appoints Douglas J. Williamson to its Board of Directors July 31, 2026 8:30 AM - StreetInsider Form SCHEDULE 13D/A BRIGHT MINDS BIOSCIENCES Filed by: McDonald Ian July 2, 2026 5:24 PM - SEC Filing Full Article List